PDF(1803 KB)

FDA 植物药监管再审视：对中药质量监管与证据评价的思考与启示——基于2026 年RFI 与FDA/EMA 联合研讨会

Re-examining FDA Botanical Drug Regulation: Reflections and Implications for TCM Quality Regulation and Evidence Evaluation —Based on the 2026 RFI and the Joint FDA/EMA Workshop